3.0.0 3583 2023-01-13T04:50:30Z 2023-01-13T04:50:30Z House H HR 2005-07-28 109 hswm00 Ways and Means Committee House Standing hswm04 Trade Subcommittee Referred to 2005-08-04T20:03:13Z Referred to 2005-07-28T14:12:35Z Protecting Free Trade in Pharmaceuticals Act of 2005 109 1551 S 2005-07-28 Read twice and referred to the Committee on Finance. Identical bill CRS 2005-08-04 hswm04 Trade Subcommittee 1 House committee actions Referred to the Subcommittee on Trade. Committee 2005-07-28 Referred to the House Committee on Ways and Means. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2005-07-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-07-28 Introduced in House IntroReferral 1000 9 Library of Congress N000143 Rep. Northup, Anne M. [R-KY-3] ANNE NORTHUP R KY M. 3 N D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2005-07-28 True B000944 Rep. Brown, Sherrod [D-OH-13] Sherrod Brown D OH 13 2005-07-28 True E000172 Rep. Emerson, Jo Ann [R-MO-8] JO EMERSON R MO ANN 8 2005-07-28 True B000420 Rep. Berry, Marion [D-AR-1] MARION BERRY D AR 1 2005-07-28 True S000033 Rep. Sanders, Bernard [I-VT-At Large] Bernard Sanders I VT 0 2005-07-28 True E000287 Rep. Emanuel, Rahm [D-IL-5] Rahm Emanuel D IL 5 2005-07-28 True G000536 Rep. Gutknecht, Gil [R-MN-1] GIL GUTKNECHT R MN 1 2005-07-28 True S001148 Rep. Simpson, Michael K. [R-ID-2] MICHAEL SIMPSON R ID K. 2 2005-07-28 True A000357 Rep. Allen, Thomas H. [D-ME-1] THOMAS ALLEN D ME H. 1 2005-09-13 False C001038 Rep. Crowley, Joseph [D-NY-7] JOSEPH CROWLEY D NY 7 2005-09-15 False Foreign Trade and International Finance Commerce Congress Consumer protection Drugs Federal advisory bodies Government Operations and Politics Health Imports Intellectual property International Affairs Legislation Patent infringement Patents Trade agreements Trade negotiations Foreign Trade and International Finance 00 2005-07-28 Introduced in House 2005-09-06T21:23:44Z Protecting Free Trade in Pharmaceuticals Act of 2005 - Amends the Bipartisan Trade Promotion Authority Act of 2002 to include among the overall trade negotiating objectives of the United States avoiding negotiating trade agreements that could restrict, or be interpreted to restrict, the access of consumers in the United States to pharmaceutical imports from countries with a pharmaceutical infrastructure that is equivalent, or superior, to that of the United States: (1) by or through the use and development of the doctrine of international patent exhaustion, as interpreted or applied by U.S. courts on the enactment of this Act; or (2) by making it a violation for the United States to enact legislation permitting pharmaceutical imports without the consent of patent owners when the products involved have been sold outside the United States.

Prohibits the U.S. Trade Representative (USTR) from: (1) entering into a bilateral or multilateral trade agreement that, with respect to the importation of pharmaceutical products without the consent of the patent owners, includes provisions identical or similar to the provisions of the United States-Singapore Free Trade Agreement, the United States-Australia Free Trade Agreement, or the United States-Morocco Free Trade Agreement; or (2) negotiating an agreement or understanding with respect to any of such provisions.

Requires the USTR, with respect to the advisory committee on matters relating to intellectual property, to ensure that, for each meeting that relates or potentially relates to the importation of pharmaceutical products into the United States, at least 10% of the committee members represent the interests of consumers of such products.

]]> Protecting Free Trade in Pharmaceuticals Act of 2005 Display Title Protecting Free Trade in Pharmaceuticals Act of 2005 Official Title as Introduced To clarify that the overall trade negotiating objectives of the United States include avoiding provisions in trade agreements that restrict the access of consumers in the United States to pharmaceutical imports, and for other purposes. Introduced in House IH Short Titles as Introduced Protecting Free Trade in Pharmaceuticals Act of 2005 Introduced in House 2005-07-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr3583ih/xml/BILLS-109hr3583ih.xml 2005-08-04 Referred to the Subcommittee on Trade. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.